Erratum: A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients

Article metrics

Correction to: Molecular Psychiatry advance online publication, 8 December 2015; doi:10.1038/mp.2015.178

Following publication of this paper, the authors noticed that Figures 5a and b contained the same image. In addition, there was a typo in Table 3 at #703. The correct figure and table appear here.

Figure 5
figure1

(ad) Efficacy outcomes in means over time.

PowerPoint slide

Table 3 Baseline biomarker levels and the probability of response to NSI-189 at day 28

Additional information

The online version of the original article can be found at 10.1038/mp.2015.178

PowerPoint slides

Rights and permissions

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Further reading